ACTIVATION AND INACTIVATION OF CANCER CHEMOTHERAPEUTIC-AGENTS BY RAT HEPATOCYTES COCULTURED WITH HUMAN-TUMOR CELL-LINES

Authors:
  • MAMC ALLEY
    MC ALLEY
  • GPG POWIS
    G POWIS
  • PAPL APPEL
    PL APPEL
  • KKKL KOOISTRA
    KL KOOISTRA
  • MLMM LIEBER
    MM LIEBER

  • 1 January 1984
    • journal article
    • research article
    • Vol. 44  (2) , 549-556
    • PMID:6692360
Abstract
Drugs which require metabolic activation lack activity in colony formation assays. In the present study, freshly isolated rat hepatocytes were utilized for the activation of drugs which are metabolized by hepatic microsomal as well as extramicrosomal enzymes. Hepatocytes in fluid medium are placed over soft-agarose matrix containing tumor-derived cells (e.g., A204 [human rhabdomyosarcoma]A549 [human lung carcinoma]) within 35-mm culture dishes; drug and/or drug vehicle is added directly to the hepatocyte layer, and cultures are incubated for 24 h prior to removal of the hepatocyte layer. Tumor cell colony formation is assessed following 7-10 days of incubation. Cyclophosphamide was used as prototype agent to assess utility of the coculture methodology. In vivo treatment of rats with phenobarbital prior to hepatocyte isolation enhances cyclophosphamide toxicity in vitro, whereas pretreatment with carbon tetrachloride markedly reduced subsequent in vitro cyclophosphamide cytotoxicity. Hepatocyte:tumor cell cocultures provide an efficient means to detect metabolic activation and inactivation of several selected cancer chemotherapeutic agents as well. In the presence of hepatocytes, the 50% growth-inhibitory concentrations for cyclophosphamide, indicine N-oxide, and procarbazine are markedly decreased, whereas the 50% growth-inhibitory concentrations for [2,5-bis-(1-aziridinyl)-3,6-diazo-1,4-cyclohexadiene-1,4-diyl]bis(carbamic acid)diethyl ester, 1,3-bis-chloro-(2-chloroethyl)-1-nitrosourea, dacarbazine, 5-fluorouracil, ftorafur, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and vincristine are significantly increased. By contrast, the 50% growth-inhibitory concentrations for actinomycin D, mitomycin C, 6-mercaptopurine, and other agents are unaffected by hepatocyte presence. Cryopreserved hepatocytes exhibit detectable levels of drug activation, although inadequate for routine use. Results suggest that hepatocyte:tumor cell cocultures may be well-suited for assessing the degree to which hepatic metabolism may activate or inactivate new anticancer drugs.

This publication has 1 reference indexed in Scilit: